Endocrinol Metab > Volume 20(4); 2005 > Article
Journal of Korean Endocrine Society 2005;20(4):407-412.
DOI: https://doi.org/10.3803/jkes.2005.20.4.407    Published online August 1, 2005.
A Case of Drug Induced Nephrogenic Diabetes Insipidus and Hyperprolactinemia in Schizophrenia Simultaneously.
Ho Yoel Ryu, Mi Young Lee, Yeon Lee, Jang Hyun Koh, Mi Jin Kim, Young Goo Shin, Choon Hee Chung
1Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wounju, Korea.
2Department of Internal Medicine, Hongik Hospital, Seoul, Korea.
In schizophrenia, when treatment using antipsychotics fails, lithium, which is known as an antimanic drug, can also be administered. It is reported that 12~20% of patients taking lithium develop nephrogenic diabetes lactotrophs. Hyperprolactinemia is induced by typical antipsychotics, as they block the dopamine-2 receptors of latotrophs in the pituitary gland. Therefore, atypical antipsychotics for decreasing the side effect, such as hyperprolactinemia, can be used. However, hyperprolactinemia can be induced by risperidone, one of the atypical antipsychotics. Here, a case of drug induced nephrogenic diabetes insipidus and simultaneous hyperprolactinemia, which occurred in a patient with schizophrenia, is reported.
Key Words: Nephrogenic Diabetes Insipidus, Hyerprolactinemia, Lithium, Risperidone
METRICS Graph View
  • 0 Crossref
  •  0 Scopus
  • 1,184 View
  • 14 Download
Related articles

Editorial Office
101-2503, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea​
Tel: +82-2-716-2428    Fax: +82-2-714-5103    E-mail: journal@endocrinology.or.kr                

Copyright © 2022 by Korean Endocrine Society.

Developed in M2PI